InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: md1225 post# 217071

Sunday, 04/26/2015 9:00:08 AM

Sunday, April 26, 2015 9:00:08 AM

Post# of 346073


I agree the possibility does exist for early results. Especially as you said if the enrollment is trending well. Partnerships always a possibility during Phase 3 trials as we know.




There is definitely a possibility of SUNRISE trial being halted in 2015.

It ALL has to do with how fast enrollment is trending, if we have first look in by end of May, we should see full enrollment by October and 2nd look in with six weeks of the full enrollment PR.

I'm very optimistic about SUNRISE and bavituximab.

But remember as Volgoat said we may see bavituximab approved for melanoma first.

Approval or trial halt is NOT my goal for PPHM in 2015, my goal is a true partner. BMY is my guess then possibly Roche then Abbvie/Calico.

I've never been more secure about my investment in PPHM then I am today. Waiting is hard, but patience I have learned. It will make my goal of early retirement and time with my children that more precious.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News